Subscribe To
Altimmune to present new data on the anti-inflammatory and anti-fibrotic properties of pemvidutide in a late-breaking presentation at the liver meeting® 2023
GAITHERSBURG, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that n...
October 25, 2023, 7:30 am
Chill brands boss likens nicotine vapes to non-alcoholic beer
Callum Somerton, the CEO of Chill Brands, talks to Proactive's Thomas Warner about the partnership he has just announced to sell its nicotine-free vap...
October 24, 2023, 9:43 am
Terns pharmaceuticals to participate in upcoming investor conferences
FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
October 19, 2023, 8:05 pm
Coca-cola: an excellent firm, but is there value present in shares?
Coca-Cola is a well-managed company with a strong set of brands and a wide economic moat. The company has expanded its portfolio through acquisitions ...
October 19, 2023, 11:39 am
New zealand will begin publishing additional monthly price indexes
New Zealand is the only OECD nation still relying on quarterly inflation data.Statistics New Zealand have announced that they'll begin publishing addi...
October 18, 2023, 12:35 am
Coca-cola is expanding to adjacent areas like coffee and alcohol, says bokeh capital's kim forrest
Kim Forrest, chief investment officer at Bokeh Capital Partners, joins 'The Exchange' to discuss bellwethers in the retail space, Urban Outfitter's un...
October 12, 2023, 2:42 pm
Akero therapeutics inc stock tanks after nash liver treatment study disappoints
Akero Therapeutics Inc shares lost roughly two-thirds of their value Tuesday morning after the company released a disappointing update on its fatty li...
October 10, 2023, 11:51 am
Akero therapeutics shares plunge on liver disease treatment's mixed results
Akero Therapeutics Inc. shares AKRO, -3.56% fell more than 60% premarket on Tuesday after the company released an update on its lead product candidate...
October 10, 2023, 8:10 am
One of our big innovations is blue moon non-alcoholic, says molson coors ceo gavin hattersley
Molson Coors CEO Gavin Hattersley joins 'Mad Money' host Jim Cramer to talk what's ahead for the company....
October 4, 2023, 8:11 pm
Diageo raising $1.7bn in bond issue as operating challenges persist
Diageo PLC (LSE:DGE) is looking to beef up its balance sheet by raising US$1.7 billion via a twin US bond issue after last week reporting the ongoing ...
October 3, 2023, 2:56 am
Constellation brands likely to provide cheer with frothy 2q revenue and earnings
Constellation Brands (NYSE:STZ) may have investors raising a glass when it reports quarter earnings ahead of the opening bell on October 5, 2023. The ...
September 29, 2023, 12:38 pm
Genflow biosciences well-funded for next r&d milestones
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) said it is funded until at least March 2025 as it summarised the significant progress it has made in t...
September 28, 2023, 3:03 am
Sagimet biosciences: recent ipo with emerging positive data in nash
Sagimet Biosciences Inc. develops FASN inhibitors for diseases related to dysfunctional lipid metabolism. Their lead candidate, Denifanstat, shows pro...
September 27, 2023, 2:48 pm
Wall street thinks madrigal pharmaceuticals could climb 93%. here's why it could happen soon.
Analysts have high hopes for Madrigal Pharmaceuticals over the coming year. Its drug resmetirom seems effective for a liver disease, non-...
September 27, 2023, 9:53 am
Australia’s monthly cpi rose to 5.2%, led by housing and transport
Australia CPI for August rose from 4.9% yoy to 5.2% yoy, in line with market expectations. Digging into the specifics, the sectors showing the most su...
September 27, 2023, 3:11 am
Hepion pharmaceuticals to participate in 2023 cantor global healthcare conference
EDISON, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Art...
September 21, 2023, 4:05 pm
Genflow biosciences primed and ready for phase i/ii trial after regulatory sign-off
Genflow Biosciences PLC (LSE:GENF, OTC:GENFF) said it has received encouraging advice from Belgium's Federal Agency for Medicines and Health Products ...
September 20, 2023, 3:24 am
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)
CONSHOHOCKEN, Pa., Sept. 14, 2023 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursui...
September 14, 2023, 8:30 pm
Madrigal (mdgl) gains on nda for nash therapy acceptance by fda
Madrigal (MDGL) gains as new drug application for resmeritom to treat nonalcoholic steatohepatitis gets...
September 14, 2023, 9:01 am
The vita coco co.: business demonstrates robust performance and continues to track against growth target
COCO is a buy based on its strong growth, increased EBITDA margin, and favorable outlook in the healthy beverage production sector. COCO operates in a...
September 12, 2023, 5:29 am